139 related articles for article (PubMed ID: 12164379)
1. Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy.
Rousselle C; Clair P; Temsamani J; Scherrmann JM
J Drug Target; 2002 Jun; 10(4):309-15. PubMed ID: 12164379
[TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity.
Rousselle C; Smirnova M; Clair P; Lefauconnier JM; Chavanieu A; Calas B; Scherrmann JM; Temsamani J
J Pharmacol Exp Ther; 2001 Jan; 296(1):124-31. PubMed ID: 11123372
[TBL] [Abstract][Full Text] [Related]
3. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.
Rousselle C; Clair P; Lefauconnier JM; Kaczorek M; Scherrmann JM; Temsamani J
Mol Pharmacol; 2000 Apr; 57(4):679-86. PubMed ID: 10727512
[TBL] [Abstract][Full Text] [Related]
4. Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy.
Rousselle C; Clair P; Smirnova M; Kolesnikov Y; Pasternak GW; Gac-Breton S; Rees AR; Scherrmann JM; Temsamani J
J Pharmacol Exp Ther; 2003 Jul; 306(1):371-6. PubMed ID: 12682214
[TBL] [Abstract][Full Text] [Related]
5. Identification and design of peptides as a new drug delivery system for the brain.
Demeule M; Régina A; Ché C; Poirier J; Nguyen T; Gabathuler R; Castaigne JP; Béliveau R
J Pharmacol Exp Ther; 2008 Mar; 324(3):1064-72. PubMed ID: 18156463
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
Wu D; Song BW; Vinters HV; Pardridge WM
J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
[TBL] [Abstract][Full Text] [Related]
7. The design and delivery of a PKA inhibitory polypeptide to treat SCA1.
Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ
J Neurochem; 2014 Oct; 131(1):101-14. PubMed ID: 24903464
[TBL] [Abstract][Full Text] [Related]
8. Delivery of peptides and proteins through the blood-brain barrier.
Bickel U; Yoshikawa T; Pardridge WM
Adv Drug Deliv Rev; 2001 Mar; 46(1-3):247-79. PubMed ID: 11259843
[TBL] [Abstract][Full Text] [Related]
9. Transport of the beta-lactam antibiotic benzylpenicillin and the dipeptide glycylsarcosine by brain capillary endothelial cells in vitro.
Török M; Huwyler J; Drewe J; Gutmann H; Fricker G
Drug Metab Dispos; 1998 Nov; 26(11):1144-8. PubMed ID: 9806958
[TBL] [Abstract][Full Text] [Related]
10. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
Saito Y; Buciak J; Yang J; Pardridge WM
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757
[TBL] [Abstract][Full Text] [Related]
11. [Strategies for drug delivery to the brain across the blood-brain barrier].
Tsuji A
Nihon Rinsho; 1998 Mar; 56(3):613-8. PubMed ID: 9549345
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
Wu D; Pardridge WM
J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978
[TBL] [Abstract][Full Text] [Related]
13. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier.
Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y
J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544
[TBL] [Abstract][Full Text] [Related]
14. Facilitated transport of benzylpenicillin through the blood-brain barrier in rats.
Suzuki H; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacobiodyn; 1989 Mar; 12(3):182-5. PubMed ID: 2760797
[TBL] [Abstract][Full Text] [Related]
15. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.
Pardridge WM; Wu D; Sakane T
Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954
[TBL] [Abstract][Full Text] [Related]
16. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
17. Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
Wu WM; Pop E; Shek E; Bodor N
J Med Chem; 1989 Aug; 32(8):1782-8. PubMed ID: 2754705
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.
Wang Z; Zhao Y; Jiang Y; Lv W; Wu L; Wang B; Lv L; Xu Q; Xin H
Sci Rep; 2015 Jul; 5():12651. PubMed ID: 26219474
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in peptide drug delivery to the brain.
Pardridge WM
Pharmacol Toxicol; 1992 Jul; 71(1):3-10. PubMed ID: 1523192
[TBL] [Abstract][Full Text] [Related]
20. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
